Post by Dealert

9.5-11.4x EV/EBITDA for a silicone components buyout is not “cheap” - it’s conviction. 🧠 Lexington Precision Corporation just bought QSR Quality Synthetic Rubber 🇺🇸 from Blue Point Capital Partners. Dealert pegs the deal at $150m-$180m EV on $16m-$17m EBITDA (and $90m-$105m revenue), implying 1.6-1.9x EV/Revenue. The tell: paying ~10-11x for a niche supplier suggests the real asset is reliability and spec-driven stickiness - not just volume. Question for deal teams: is this multiple about medical defensibility, China growth optionality, or simply scarcity of scaled silicone platforms? 🔗 Full details: https://lnkd.in/e69G8NTc #MergersAndAcquisitions #PrivateEquity #USPrivateEquity #BusinessGrowth #Healthcare #MedTech